Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

Bone Marrow Transplantation

Volumn 23, Issue 10, 1999, Pages 1003-1006

  Moreau, P ^a   Milpied, N ^a   Mahe B ^a   Juge Morineau, N ^a   Rapp, M J ^a   Bataille, R ^a   Harousseau, J L ^a  

^a HÔTEL DIEU   (France)

Author keywords

Autologous stem cell transplantation; High dose chemotherapy; Melphalan; Myeloma

Indexed keywords

BETA 2 MICROGLOBULIN; MELPHALAN;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROBABILITY; RELAPSE; THROMBOCYTOPENIA; VOMITING;

EID: 0032969403     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701763     Document Type: Article

References (18)

1. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. New Engl J Med 1996; 335: 91-97.
2. Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
3. Cunningham D, Paz-Ares L, Milan S et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12: 759-763.
4. Selby PJ, McElwain TJ, Nandi AC et al. Multiple myeloma treated with high-dose intravenous melphalan. Br J Haematol 1987; 66: 55-62.
5. Samuels BJ, Bitran JD. High-dose intravenous melphalan: a review. J Clin Oncol 1995; 13:1786-1799.
6. 2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity. Br J Haematol 1996; 95: 527-530.
7. Gore ME, Selby PJ, Viner C et al. Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 1989; 2: 879-882.
8. Bensinger WI, Longon K, Appelbaum F et al. Peripheral blood stem cells collected after recombinant granulocyte colony-stimulating factor: an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
9. Prince HM, Imrie K, Sutherland DR et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors of management of inadequate collections. Br J Haematol 1996; 93: 142-145.
10. Olivieri A, Corvatta L, Montanari M et al. Paroxysmal atrial fibrillation after high-dose melphalan in five patients auto-transplanted with blood progenitor cells. Bone Marrow Transplant 1998; 21: 1049-1053.
11. Harousseau JL, Milpied N, Garand R et al. High-dose melphalan and autologous bone marrow transplantation in high-risk multiple myeloma. Br J Haematol 1987; 67: 493-496.
12. Barlogie B, Alexanian R, Smallwood L et al. Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 1988; 72: 2015-2019.
13. Barlogie B, Jagannath S, Dixon DO et al. High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma. Blood 1990; 76: 677-680.
14. Harousseau JL, Milpied N, Laporte JP et al. Double intensive therapy in high-risk multiple myeloma. Blood 1992; 79: 2827-2833.
15. Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-956.
16. Mehta J, Tricot G, Jagannath S et al. Salvage autologous or allogeneic transplantation for multiple myeloma. Bone Marrow Transplant 1998; 21: 887-892.
17. Tricot G, Jagannath S, Vesole DH et al. Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. Bone Marrow Transplant 1995; 16: 7-11.
18. Palumbo A, Pileri A, Triolo S et al. Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patients. Bone Marrow Transplant 1997; 17: 23-29.